FOXP1 and ovarian carcinoma: As we found that FOXP1 upregulation in ovarian cancer tumorsphere was significantly prevented by EGCG, FOXP1 may constitute an attractive target for the development of therapeutics to eliminate CSC in ovarian cancer [46].